Literature DB >> 35271300

Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation.

Caleb R Glassman1, Naotaka Tsutsumi1,2, Robert A Saxton1,2, Patrick J Lupardus1, Kevin M Jude1,2, K Christopher Garcia1,2,3.   

Abstract

Cytokines signal through cell surface receptor dimers to initiate activation of intracellular Janus kinases (JAKs). We report the 3.6-angstrom-resolution cryo-electron microscopy structure of full-length JAK1 complexed with a cytokine receptor intracellular domain Box1 and Box2 regions captured as an activated homodimer bearing the valine→phenylalanine (VF) mutation prevalent in myeloproliferative neoplasms. The seven domains of JAK1 form an extended structural unit, the dimerization of which is mediated by close-packing of the pseudokinase (PK) domains from the monomeric subunits. The oncogenic VF mutation lies within the core of the JAK1 PK interdimer interface, enhancing packing complementarity to facilitate ligand-independent activation. The carboxy-terminal tyrosine kinase domains are poised for transactivation and to phosphorylate the receptor STAT (signal transducer and activator of transcription)-recruiting motifs projecting from the overhanging FERM (four-point-one, ezrin, radixin, moesin)-SH2 (Src homology 2)-domains. Mapping of constitutively active JAK mutants supports a two-step allosteric activation mechanism and reveals opportunities for selective therapeutic targeting of oncogenic JAK signaling.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35271300      PMCID: PMC9306331          DOI: 10.1126/science.abn8933

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  73 in total

1.  Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.

Authors:  Stephan Wilmes; Maximillian Hafer; Joni Vuorio; Julie A Tucker; Hauke Winkelmann; Sara Löchte; Tess A Stanly; Katiuska D Pulgar Prieto; Chetan Poojari; Vivek Sharma; Christian P Richter; Rainer Kurre; Stevan R Hubbard; K Christopher Garcia; Ignacio Moraga; Ilpo Vattulainen; Ian S Hitchcock; Jacob Piehler
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

Review 2.  JAK2 the future: therapeutic strategies for JAK-dependent malignancies.

Authors:  Lindsay M LaFave; Ross L Levine
Journal:  Trends Pharmacol Sci       Date:  2012-09-17       Impact factor: 14.819

3.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

Review 4.  The JAK-STAT pathway at twenty.

Authors:  George R Stark; James E Darnell
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

5.  Structural snapshots of full-length Jak1, a transmembrane gp130/IL-6/IL-6Rα cytokine receptor complex, and the receptor-Jak1 holocomplex.

Authors:  Patrick J Lupardus; Georgios Skiniotis; Amanda J Rice; Christoph Thomas; Suzanne Fischer; Thomas Walz; K Christopher Garcia
Journal:  Structure       Date:  2011-01-12       Impact factor: 5.006

Review 6.  JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.

Authors:  Yiming Luo; Madison Alexander; Massimo Gadina; John J O'Shea; Francoise Meylan; Daniella M Schwartz
Journal:  J Allergy Clin Immunol       Date:  2021-10       Impact factor: 14.290

7.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

Authors:  P Macchi; A Villa; S Giliani; M G Sacco; A Frattini; F Porta; A G Ugazio; J A Johnston; F Candotti; J J O'Shea
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

8.  Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases.

Authors:  Angela V Toms; Anagha Deshpande; Randall McNally; Youngjee Jeong; Julia M Rogers; Chae Un Kim; Sol M Gruner; Scott B Ficarro; Jarrod A Marto; Martin Sattler; James D Griffin; Michael J Eck
Journal:  Nat Struct Mol Biol       Date:  2013-09-08       Impact factor: 15.369

9.  Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects.

Authors:  D A Harrison; R Binari; T S Nahreini; M Gilman; N Perrimon
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

10.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix.

Authors:  Dorothee Liebschner; Pavel V Afonine; Matthew L Baker; Gábor Bunkóczi; Vincent B Chen; Tristan I Croll; Bradley Hintze; Li Wei Hung; Swati Jain; Airlie J McCoy; Nigel W Moriarty; Robert D Oeffner; Billy K Poon; Michael G Prisant; Randy J Read; Jane S Richardson; David C Richardson; Massimo D Sammito; Oleg V Sobolev; Duncan H Stockwell; Thomas C Terwilliger; Alexandre G Urzhumtsev; Lizbeth L Videau; Christopher J Williams; Paul D Adams
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-10-02       Impact factor: 7.652

View more
  6 in total

Review 1.  Emerging principles of cytokine pharmacology and therapeutics.

Authors:  Robert A Saxton; Caleb R Glassman; K Christopher Garcia
Journal:  Nat Rev Drug Discov       Date:  2022-09-21       Impact factor: 112.288

Review 2.  Looking lively: emerging principles of pseudokinase signaling.

Authors:  Joshua B Sheetz; Mark A Lemmon
Journal:  Trends Biochem Sci       Date:  2022-05-16       Impact factor: 14.264

3.  Deciphering signal transduction networks in the liver by mechanistic mathematical modelling.

Authors:  Lorenza A D'Alessandro; Ursula Klingmüller; Marcel Schilling
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

4.  Surrogate cytokine agonists: promising agents against COVID-19.

Authors:  Zemin Lin; Jianping Zuo; Shijun He
Journal:  Signal Transduct Target Ther       Date:  2022-05-06

Review 5.  JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.

Authors:  Charlotte Ej Downes; Barbara J McClure; Daniel P McDougal; Susan L Heatley; John B Bruning; Daniel Thomas; David T Yeung; Deborah L White
Journal:  Front Cell Dev Biol       Date:  2022-07-12

Review 6.  Recent advances in targeting protein kinases and pseudokinases in cancer biology.

Authors:  Kristina Riegel; Parthiban Vijayarangakannan; Petros Kechagioglou; Katarzyna Bogucka; Krishnaraj Rajalingam
Journal:  Front Cell Dev Biol       Date:  2022-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.